Outset Medical (OM)
(Delayed Data from NSDQ)
$0.71 USD
-0.01 (-0.95%)
Updated Aug 23, 2024 03:59 PM ET
After-Market: $0.71 0.00 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum D VGM
Cash flow Statements
Fiscal Year End for Outset Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -172.80 | -162.96 | -131.94 | -121.49 | -68.30 |
Depreciation/Amortization & Depletion | -0.56 | 5.62 | 7.13 | 3.21 | 0.50 |
Net Change from Assets/Liabilities | -0.77 | -21.14 | -25.60 | -5.85 | -1.60 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 42.76 | 32.75 | 20.14 | 25.12 | -0.90 |
Net Cash From Operating Activities | -131.37 | -145.73 | -130.26 | -99.02 | -70.29 |
Property & Equipment | -3.44 | -8.33 | -3.11 | -9.08 | -3.29 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 86.47 | -57.97 | -139.40 | 13.02 | 77.59 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 83.03 | -66.30 | -142.51 | 3.95 | 74.30 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 10.43 | 8.04 | 160.15 | 387.05 | 0.44 |
Issuance (Repayment) of Debt | 33.23 | 64.86 | 0.00 | -1.36 | -0.01 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | -0.18 |
Net Cash from Financing Activities | 43.65 | 72.90 | 160.15 | 385.68 | 0.25 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -4.70 | -139.13 | -112.62 | 290.61 | 4.25 |
Cash at Beginning of Period | 76.53 | 215.66 | 328.28 | 37.67 | 33.42 |
Cash at End of Period | 71.84 | 76.53 | 215.66 | 328.28 | 37.67 |
Diluted Net EPS | -3.48 | -3.38 | -2.89 | -4.85 | NA |
Fiscal Year End for Outset Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -74.40 | -39.94 | -172.80 | -134.20 | -88.02 |
Depreciation/Amortization & Depletion | 0.00 | -0.12 | -0.56 | -0.74 | -0.45 |
Net Change from Assets/Liabilities | -27.36 | -15.46 | -0.77 | -4.75 | -5.67 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 22.51 | 9.61 | 42.76 | 32.75 | 21.21 |
Net Cash From Operating Activities | -79.25 | -45.91 | -131.37 | -106.93 | -72.93 |
Property & Equipment | -0.47 | -0.35 | -3.44 | -2.39 | -1.61 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -19.62 | -58.68 | 86.47 | 61.99 | 31.40 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -20.09 | -59.03 | 83.03 | 59.60 | 29.80 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.16 | 2.09 | 10.43 | 10.42 | 6.32 |
Issuance (Repayment) of Debt | 66.52 | 66.52 | 33.23 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 68.69 | 68.61 | 43.65 | 10.42 | 6.32 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -30.65 | -36.33 | -4.70 | -36.91 | -36.82 |
Cash at Beginning of Period | 71.84 | 71.84 | 76.53 | 76.53 | 76.53 |
Cash at End of Period | 41.19 | 35.51 | 71.84 | 39.63 | 39.72 |
Diluted Net EPS | -0.66 | -0.78 | -0.75 | -0.93 | -0.90 |